LUNA LABS USA LLC — Department of Defense STTR Phase II: READIPLEX - IMPLANTABLE BIOSENSOR FOR CONTINUOUS MONITORING OF INDICATORS OF HUMAN PERFORM
LUNA LABS USA LLC — STTR Phase II award from Department of Defense.
Phase II STTR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- At $1,699,996, this is a large obligation for typical SBIR Phase sizing — worth reviewing for scope breadth and teaming opportunity.
- Tagged technology areas: Human Performance & Medical, Sensors & Sensor Fusion. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Luna Labs USA LLC received nearly $1.7 million from the Air Force for Phase II of an STTR project to develop READIPLEX, an implantable biosensor. This device will continuously monitor indicators of human performance to support military health and readiness.
- Amount
- $1,699,996
- Agency
- Department of Defense · Department of the Air Force
- Program / Phase
- STTR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- VA
- Period
- 2025-05-19 → 2027-08-19
Technology domains
Description
STTR PHASE II: READIPLEX - IMPLANTABLE BIOSENSOR FOR CONTINUOUS MONITORING OF INDICATORS OF HUMAN PERFORMANCE